264 related articles for article (PubMed ID: 31812892)
21. Postoperative Radiotherapy Contributes to the Survival Benefit of Breast-Conserving Therapy over Mastectomy.
Chen CY; Zheng SY; Cai G; Xu C; Cai R; Li M; Shen KW; Chen XS; Ou D; Qi WX; Cao L; Chen JY
J Oncol; 2022; 2022():4145872. PubMed ID: 36618070
[TBL] [Abstract][Full Text] [Related]
22. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
[TBL] [Abstract][Full Text] [Related]
23. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for regional nodal relapse in breast cancer patients with one to three positive axillary nodes.
Yates L; Kirby A; Crichton S; Gillett C; Cane P; Fentiman I; Sawyer E
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2093-103. PubMed ID: 21530101
[TBL] [Abstract][Full Text] [Related]
25. Breast-conserving surgery with or without irradiation in women with invasive ductal carcinoma of the breast receiving preoperative systemic therapy: A cohort study.
Zhang J; Lu CY; Qin L; Chen HM; Wu SY
Breast; 2020 Dec; 54():139-147. PubMed ID: 33049657
[TBL] [Abstract][Full Text] [Related]
26. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
[TBL] [Abstract][Full Text] [Related]
27. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
[No Abstract] [Full Text] [Related]
28. Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial.
Jagsi R; Barlow WE; Woodward WA; Connolly E; Mahtani R; Shumway D; Speers C; Stecklein SR; Zeidan Y; Zhang H; Sharma P; Pusztai L; Hortobagyi GN; Kalinsky K
JAMA Oncol; 2023 Aug; 9(8):1083-1089. PubMed ID: 37410451
[TBL] [Abstract][Full Text] [Related]
29. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial.
Polgár C; Fodor J; Major T; Sulyok Z; Kásler M
Radiother Oncol; 2013 Aug; 108(2):197-202. PubMed ID: 23742961
[TBL] [Abstract][Full Text] [Related]
30. Regional nodal recurrence in the management of breast cancer patients with one to three positive axillary lymph nodes. Outcome of patients following tangential irradiation without a separate nodal field.
Stranzl H; Peintinger F; Ofner P; Prettenhofer U; Mayer R; Hackl A
Strahlenther Onkol; 2004 Oct; 180(10):623-8. PubMed ID: 15480510
[TBL] [Abstract][Full Text] [Related]
31. Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial.
Fastner G; Sedlmayer F; Widder J; Metz M; Geinitz H; Kapp K; Fesl C; Sölkner L; Greil R; Jakesz R; Kwasny W; Heck D; Bjelic-Radisic V; Balic M; Stöger H; Wieder U; Zwrtek R; Semmler D; Horvath W; Melbinger-Zeinitzer E; Wiesholzer M; Wette V; Gnant M
Eur J Cancer; 2020 Mar; 127():12-20. PubMed ID: 31962198
[TBL] [Abstract][Full Text] [Related]
32. Breast-conservative surgery with and without radiotherapy in patients aged 55-75 years with early-stage breast cancer: a prospective, randomized, multicenter trial analysis after 108 months of median follow-up.
Tinterri C; Gatzemeier W; Costa A; Gentilini MA; Zanini V; Regolo L; Pedrazzoli C; Rondini E; Amanti C; Gentile G; Taffurelli M; Fenaroli P; Tondini C; Sacchetto G; Sismondi P; Murgo R; Orlandi M; Cianchetti E; Andreoli C
Ann Surg Oncol; 2014 Feb; 21(2):408-15. PubMed ID: 24197757
[TBL] [Abstract][Full Text] [Related]
33. Additional radiotherapy to breast-conserving surgery is an optional treatment for de novo stage IV breast cancer: A population-based analysis.
Wang J; Yang SP; Zhou P; Lian CL; Lei J; Hua L; He ZY; Wu SG
Cancer Med; 2021 Mar; 10(5):1634-1643. PubMed ID: 33586323
[TBL] [Abstract][Full Text] [Related]
34. Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial.
Poortmans PM; Weltens C; Fortpied C; Kirkove C; Peignaux-Casasnovas K; Budach V; van der Leij F; Vonk E; Weidner N; Rivera S; van Tienhoven G; Fourquet A; Noel G; Valli M; Guckenberger M; Koiter E; Racadot S; Abdah-Bortnyak R; Van Limbergen EF; Engelen A; De Brouwer P; Struikmans H; Bartelink H;
Lancet Oncol; 2020 Dec; 21(12):1602-1610. PubMed ID: 33152277
[TBL] [Abstract][Full Text] [Related]
35. Impact of Regional Nodal Irradiation for Breast Cancer Patients with Supraclavicular and/or Internal Mammary Lymph Node Involvement: A Multicenter, Retrospective Study (KROG 16-14).
Kim K; Jeong Y; Shin KH; Kim JH; Ahn SD; Kim SS; Suh CO; Kim YB; Choi DH; Park W; Cha J; Chun M; Lee DS; Lee SY; Kim JH; Park HJ; Jung W
Cancer Res Treat; 2019 Oct; 51(4):1500-1508. PubMed ID: 30913866
[TBL] [Abstract][Full Text] [Related]
36. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
[No Abstract] [Full Text] [Related]
37. Comparison of Treatment Outcomes With Breast-conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I Breast Cancer: A Propensity Score-matched Analysis.
Wang J; Wang S; Tang Y; Jing H; Sun G; Jin J; Liu Y; Song Y; Wang W; Fang H; Ren H; Yu Z; Li Y
Clin Breast Cancer; 2018 Oct; 18(5):e975-e984. PubMed ID: 30054238
[TBL] [Abstract][Full Text] [Related]
38. Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 cases.
Doré M; Cutuli B; Cellier P; Campion L; Le Blanc M
Radiat Oncol; 2015 Aug; 10():161. PubMed ID: 26238442
[TBL] [Abstract][Full Text] [Related]
39. Postmastectomy internal mammary nodal irradiation: a long-term outcome.
Aleknavičius E; Atkočius V; Kuzmickienė I; Steponavičienė R
Medicina (Kaunas); 2014; 50(4):230-6. PubMed ID: 25458960
[TBL] [Abstract][Full Text] [Related]
40. Ipsilateral breast tumor control following hypofractionated and conventional fractionated whole-breast irradiation for early breast cancer: a long-term follow-up.
Yoshida-Ichikawa Y; Horimoto Y; Shikama N; Yanagisawa N; Koyanagi A; Arakawa A; Saito M; Karasawa K
Breast Cancer; 2021 Jan; 28(1):92-98. PubMed ID: 32719997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
